Desregulação de IL-8 e Claudina-2 no esôfago de pacientes com COVID-19 pós-aguda: implicações para a disfunção da barreira epitelial
Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, has revealed a series of symptoms beyond the respiratory system, including significant gastrointestinal manifestations. Evidence suggests that these symptoms may persist for months after hospital discharge, potentially leading to long-term complications. In this context, the integrity of the esophageal barrier is essential to prevent symptoms such as heartburn and acid reflux. The study aimed to determine the prevalence of esophageal symptoms in post-acute COVID-19 syndrome (PACS) and their possible association with changes in the integrity of the esophageal epithelial barrier. This is a prospective cohort study conducted at a university hospital with individuals hospitalized for COVID-19. Assessments were carried out during hospitalization and between 3 to 6 months after discharge, using questionnaires such as GSRS and RDQ, as well as upper digestive endoscopy with biopsies of the esophageal mucosa. Transepithelial electrical resistance (RET), permeability, and the expression of inflammatory cytokines and junctional proteins were analyzed. The population consisted of 55 individuals, and a significant increase in the intensity and frequency of gastroesophageal symptoms, such as heartburn and reflux, was observed during and after COVID-19. RET and esophageal mucosal permeability were significantly altered in post-COVID patients, with increased levels of IL-8 and Claudin-2. It is concluded that inflammation and esophageal barrier…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 55 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.